. Author manuscript; available in PMC: 2022 Oct 1.

Published in final edited form as: Gynecol Oncol. 2021 Aug 6;163(1):93–99. doi: 10.1016/j.ygyno.2021.07.033

Table 4:

Adverse cardiac events for both Arm I and Arm II

Table (Supp) Cardiac AEs

	*Any Cardiac AE (During Chemotherapy)*
Arm	Yes	No
1	1	27
2	3	29
	**Cardiac AE Type (N) (During Chemotherapy)***
Arm	Palpitations	Sinus Tachycardia	Vent. Arrhythmia
1	0	1	0
2	2	0	1
	*Any Cardiac AE (Trastuzumab Maintenance)*
Arm	Left Ventricular systolic dysfunction
	Yes	No